Polaryx Therapeutics, Inc. Common Stock
NASDAQ:PLYXBiotechnology
Healthcare
$1.61 -0.87%
-$0.02 today
- Market cap
- $80.25M
- Beta
- 0.00
- P/E (TTM)
- -16.7
- EPS (TTM)
- -$0.14
52W Low $2.01High $48.91
Volume 0.02M
Average 0.34M
Price history
Polaryx Therapeutics, Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-95.40%
Period high
$35.00
Period low
$1.60
Latest
$1.61
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Sep 14, 2026 | Sep 11, 2026 | |
| 8-K | Sep 1, 2026 | Sep 1, 2026 | |
| 10-Q | Aug 13, 2026 | Aug 13, 2026 | |
| ARS | Jul 28, 2026 | Jul 28, 2026 | |
| DEFA14A | Jul 28, 2026 | Jul 28, 2026 | |
| DEF 14A | Jul 28, 2026 | Jul 28, 2026 | |
| S-8 | Jul 24, 2026 | Jul 24, 2026 | |
| 8-K | Jul 21, 2026 | Jul 21, 2026 | |
| 8-K | Jul 17, 2026 | Jul 17, 2026 | |
| 4 | May 28, 2026 | May 28, 2026 | |
| 8-K | May 28, 2026 | May 28, 2026 | |
| 10-Q | May 15, 2026 | May 14, 2026 | |
| 10-K | Mar 24, 2026 | Mar 23, 2026 | |
| 4 | Feb 20, 2026 | Feb 20, 2026 |
Competitors
Who does Polaryx Therapeutics, Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about PLYX's filings, answered from its disclosures.
What is the latest PLYX filing?
The latest filing shown is 10-Q dated Nov 12, 2026.
How many recent filings does PLYX have?
Intrinsic Alpha currently shows 20 recent filings for PLYX.
Continue the stock analysis
Jump to another research area for this company.